Yusuke Yamaguchi

Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan

Tadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi et al. · Journal of the American Society of Nephrology · 2020 · 196 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD

Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka et al. · Kidney International Reports · 2021 · 64 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis

Tadao Akizawa, Yusuke Yamaguchi, Tetsuro Otsuka et al. · ˜The œNephron journals/Nephron journals · 2020 · 63 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals

Yusuke Yamaguchi, Takanori Moriki, Atsuko Igari et al. · Thrombosis Research · 2013 · 52 citations

Medicine, Biomedical Engineering, Hematology +14

ABO-incompatible kidney transplantation in a single-center trial.

Kazuhiro Takahashi, Takashi Yagisawa, K Sonda et al. · PubMed · 1993 · 41 citations

Medicine, Nephrology, Surgery +14